Mobia Medical Q1 Revenue Doubles to $12.07M, But EPS Loss Widens to $(19.30)
MOBI sits 22% above its 52-week low of $11.11.
Summary
Mobia Medical reported Q1 2026 revenue of $12.07 million, more than doubling year-over-year due to strong IPG unit sales and accelerating commercial rollout. Despite this significant top-line growth, the company's net loss widened to $(17.74) million, pushing diluted loss per share to $(19.30) from $(12.97) in the prior year. The impressive revenue growth is overshadowed by the substantial and increasing losses, indicating significant cash burn and a challenging path to profitability.
At the time of this announcement, MOBI was trading at $13.57 on NASDAQ in the Life Sciences sector. The 52-week trading range was $11.11 to $14.77. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.